Robert Goodin, MD
Orthopaedic Surgery · Louisville, KYNPI 1912998485
Payments from drug & device makers
Across 42 payments — averaging $59.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$945
- Zimmer Biomet$781
- Amgen$205
- Smith+Nephew$193
- Stryker$126
- Treace Medical Concepts, Inc.$60
- plus $171 from 10 others
What the payments were for
- Food & beverage$1,536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 1 | $945 |
| Zimmer Biomet | 7 | $781 |
| Amgen(2 entities) | 19 | $205 |
| Smith+Nephew | 2 | $193 |
| Stryker | 1 | $126 |
| Treace Medical Concepts, Inc. | 1 | $60 |
| Vericel Corporation | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $21 |
| AbbVie | 1 | $19 |
| Baudax Bio Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| DJO, LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JII Unicondylar Knee System$148
- Persona$132
- Oxford$131
- PROPHECY$126
- AUGMENT INJECTABLE$126
- EASYFUSE$126
- ROSA-Knee$126
How this compares
$2,481 in reported general payments places this provider in the 30th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 581 | $5,349 |
| Celecoxib | 163 | $5,287 |
| Diclofenac Sodium | 196 | $4,435 |
| Meloxicam | 1,296 | $3,350 |
| Prednisone | 397 | $1,367 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 119 | $1,168 |
| Mupirocin | 92 | $648 |
| Methylprednisolone | 93 | $474 |
| Ibuprofen | 43 | $330 |
| Tramadol Hcl | 96 | $308 |
| Amoxicillin | 230 | $237 |
| Ondansetron Hcl | 18 | $145 |
| Clindamycin Hcl | 61 | $109 |
| Cyclobenzaprine Hcl | 17 | $86 |
| Cephalexin | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Louisville
- Arthur MalkaniLouisville$9.9M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.6M
- Akbar NawabLouisville$1M
- Joseph GreeneLouisville$584K
- Rodolfo Zamora RendichLouisville$539K
- Tyler KellerLouisville$401K
- Madhusudhan YakkantiLouisville$360K
- Kevin HarreldLouisville$313K
- George QuillLouisville$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.